Stocks and Investing
Stocks and Investing
Fri, March 25, 2022
[ Fri, Mar 25th 2022
] - WOPRAI
[ Fri, Mar 25th 2022
] - WOPRAI
[ Fri, Mar 25th 2022
] - WOPRAI
[ Fri, Mar 25th 2022
] - WOPRAI
[ Fri, Mar 25th 2022
] - WOPRAI
[ Fri, Mar 25th 2022
] - WOPRAI
[ Fri, Mar 25th 2022
] - WOPRAI
[ Fri, Mar 25th 2022
] - WOPRAI
[ Fri, Mar 25th 2022
] - WOPRAI
[ Fri, Mar 25th 2022
] - WOPRAI
[ Fri, Mar 25th 2022
] - WOPRAI
[ Fri, Mar 25th 2022
] - WOPRAI
Thu, March 24, 2022
[ Thu, Mar 24th 2022
] - WOPRAI
[ Thu, Mar 24th 2022
] - WOPRAI
[ Thu, Mar 24th 2022
] - WOPRAI
[ Thu, Mar 24th 2022
] - WOPRAI
[ Thu, Mar 24th 2022
] - WOPRAI
[ Thu, Mar 24th 2022
] - WOPRAI
[ Thu, Mar 24th 2022
] - WOPRAI
[ Thu, Mar 24th 2022
] - WOPRAI
[ Thu, Mar 24th 2022
] - WOPRAI
[ Thu, Mar 24th 2022
] - WOPRAI
[ Thu, Mar 24th 2022
] - WOPRAI
[ Thu, Mar 24th 2022
] - WOPRAI
[ Thu, Mar 24th 2022
] - WOPRAI
[ Thu, Mar 24th 2022
] - WOPRAI
[ Thu, Mar 24th 2022
] - WOPRAI
[ Thu, Mar 24th 2022
] - WOPRAI
Liisa Bayko Maintained (VRTX) at Buy and Held Target at $265 on, Mar 24th, 2022
Liisa Bayko of Evercore ISI Group, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Buy and Held Target at $265 on, Mar 24th, 2022.
Liisa has made no other calls on VRTX in the last 4 months.
There are 8 other peers that have a rating on VRTX. Out of the 8 peers that are also analyzing VRTX, 2 agree with Liisa's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Brian Abrahams of "RBC Capital" Maintained at Hold and Held Target at $269 on, Wednesday, February 16th, 2022
- Paul Matteis of "Stifel" Maintained at Hold with Increased Target to $222 on, Thursday, January 27th, 2022
These are the ratings of the 6 analyists that currently disagree with Liisa
- Brian Skorney of "Baird" Maintained at Buy and Held Target at $240 on, Wednesday, March 23rd, 2022
- Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy and Held Target at $275 on, Thursday, January 27th, 2022
- Evan Seigerman of "BMO Capital" Upgraded from Hold to Buy and Increased Target to $274 on, Thursday, January 20th, 2022
- Mohit Bansal of "Wells Fargo" Initiated at Buy and Held Target at $270 on, Thursday, December 9th, 2021
- Robyn Karnauskas of "Truist Securities" Maintained at Strong Buy with Increased Target to $341 on, Wednesday, December 1st, 2021
- Debjit Chattopadhyay of "Guggenheim" Maintained at Strong Buy with Increased Target to $286 on, Wednesday, December 1st, 2021
Contributing Sources